CAS 1203494-49-8

Fórmula: C19H23N3O6S2

InChI: InChI=1S/C19H23N3O6S2/c20-15-3-1-4-16(13-15)29(23,24)21-7-2-8-22(10-9-21)30(25,26)17-5-6-18-19(14-17)28-12-11-27-18/h1,3-6,13-14H,2,7-12,20H2

Clave InChI: GMHIOMMKSMSRLY-UHFFFAOYSA-N

SMILES: C1CN(CCN(C1)S(=O)(=O)C2=CC=CC(=C2)N)S(=O)(=O)C3=CC4=C(C=C3)OCCO4

DASA-58

CAS: 1203494-49-8

DASA-58

Fórmula: C₁₉H₂₃N₃O₆S₂

Pureza: ≥95%

Peso molecular: 453.53

Ref: 54-BUP05900

DASA-58

CAS: 1203494-49-8

Fórmula: C₁₉H₂₃N₃O₆S₂

Pureza: 98%

Forma y color: Solid

Peso molecular: 453.5324

Ref: IN-DA008TLO

DASA-58

CAS: 1203494-49-8

3-((4-((2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)sulfonyl)-1,4-diazepan-1-yl)sulfonyl)aniline

Fórmula: C₁₉H₂₃N₃O₆S₂

Pureza: 98%

Peso molecular: 453.53

Ref: IN-DG629987

DASA-58

CAS: 1203494-49-8

DASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.

Fórmula: C₁₉H₂₃N₃O₆S₂

Pureza: 96.96% - 99.28%

Forma y color: Solid

Peso molecular: 453.532

Ref: TM-T6816

DASA-58

CAS: 1203494-49-8

DASA-58 is an experimental drug that is used to treat inflammatory and autoimmune diseases and cancer. It is a benzimidazole compound that inhibits the function of DNA polymerase, mitochondrial membrane potential, and mitochondrial ATP production. DASA-58 has been shown to be effective in reducing the size of metastatic colorectal cancer tumors in mice by decreasing the energy metabolism of cancer cells. This drug also has anti-tumor effects on malignant brain tissue in experimental models. DASA-58 inhibits proliferation and migration of epithelial cells by blocking the epithelial mesenchymal transition (EMT). DASA-58 also has eye protecting effects; it can prevent damage to retinal neurons caused by oxidative stress.

Fórmula: C₁₉H₂₃N₃O₆S₂

Pureza: Min. 95%

Peso molecular: 453.53 g/mol

Ref: 3D-DYB49449